Cerenovus, a part of Johnson & Johnson Medical Devices Companies, has launched a new registry to gather and examine stroke-inducing blood clots removed from the brain with its EMBOTRAP II Revascularization Device.
US-based PerkinElmer has received CE-IVD mark for its Vanadis NIPT system, which enables the firm to commercialise and distribute the product throughout Europe and other countries that recognise CE marking.
Royal Philips has introduced a comprehensive and open platform called IntelliSpace Discovery 3.0 to enable development of artificial intelligence assets and their deployment in radiology to help teams carry out clinical and translational research.
Cellanyx has reported results of a prostate cancer clinical trial that indicated the ability of its live tumor cell phenotypic biomarker test in identifying patients suffering from low and intermediate grade prostate cancer who are at risk of aggressive disease progression.
US-based diversified technology company Colfax has signed a definitive agreement to acquire DJO Global, a provider of orthopaedic devices, software and services, from private equity funds managed by Blackstone for $3.15bn in cash.